cervical cancer

Interesting Cases

Reconstruction of an Irradiated Perineal Wound With a Superior Gluteal Artery Perforator Flap

03/27/2021

A 67-year-old woman presented with a nonhealing perineal wound following chemoradiation for cervical cancer. The defect measured 6 cm, with significant underlying dead space and exposed coccyx .

A 67-year-old woman presented...

03/27/2021

ePlasty

News

Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer

06/23/2020

Among patients with early-stage cervical cancer, minimally invasive radical hysterectomy is associated with an elevated risk of recurrence and death compared with open radical hysterectomy, according to a recent...

Among...

06/23/2020

Journal of Clinical Pathways

Guideline Updates

ASTRO Releases First Radiation Therapy Guideline for Cervical Cancer

06/17/2020

The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline with recommendations for external beam radiation, chemoradiation, and brachytherapy for postoperative and definitive management of...

The...

06/17/2020

Journal of Clinical Pathways

Research in Review

Fewer Incidences of Cervical Intraepithelial Neoplasia With HPV Vaccine

10/05/2016

JCP Editors

In a study published in JAMA Oncology, researchers a found that, after adjusting for changes in screening, there was a decrease in all-grade cervical intraepithelial neoplasia (CIN), a known link to cervical cancer,...

In a...

10/05/2016

Journal of Clinical Pathways

Department

Better Cervical and Endometrial Cancer Outcomes With IMRT

10/03/2016

JCP Editors

Patients treated with intensity-modulated radiation therapy (IMRT) for cervical or endometrial cancer have fewer adverse events and experience better quality of life than those treated with conventional radiation...

...

10/03/2016

Journal of Clinical Pathways

Conference Coverage

2016 Genitourinary Cancers Symposium

01/28/2016

JCP Editors

The American Society of Clinical Oncology’s 2016 Genitourinary Cancers Symposium was held earlier this month (January 7-9) in San Francisco, California, where the brightest professionals in urology, oncology, and...

The...

01/28/2016

Journal of Clinical Pathways

Research in Review

Five-Factor Risk Assessment Identifies Patients Who Most Benefit from Bevacizumab Treatment

12/23/2015

JCP Editors

Cervical cancer patients categorized as mid- or high-risk using the Moore criteria can benefit from adding bevacizumab to their chemotherapy regimen, according to a new study published in Clinical Cancer Research....

...

12/23/2015

Journal of Clinical Pathways